EU Clears Suzano's Over $3 Billion Deal for Kimberly-Clark's International Tissue Business
By Edith Hancock
The European Union cleared Suzano's acquisition of a majority stake in Kimberly-Clark International Family Care & Professional, saying the deal would not raise competition concerns in the EU.
The European Commission said Monday that wood pulp supplier Suzano's over $3 billion deal for Kimberly Clark's tissue business would not raise significant concerns.
The commission said that rival tissue producers in the bloc will continue to have access to sufficient supplies of bleached eucalyptus kraft pulp--widely used in producing tissue and writing paper--despite Suzano's position as the leading supplier worldwide. Officials also said in a statement Monday that competitors would have enough alternative suppliers if Suzano were to restrict supplies or worsen business terms for other tissue producers.
Write to Edith Hancock at edith.hancock@wsj.com
(END) Dow Jones Newswires
May 11, 2026 10:36 ET (14:36 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States